tiprankstipranks
CytomX Therapeutics upgraded to Buy from Hold at Jefferies
PremiumThe FlyCytomX Therapeutics upgraded to Buy from Hold at Jefferies
9d ago
Amgen price target raised to $325 from $315 at BofA
PremiumThe Fly
Amgen price target raised to $325 from $315 at BofA
12d ago
Amgen price target lowered to $328 from $332 at RBC Capital
PremiumThe Fly
Amgen price target lowered to $328 from $332 at RBC Capital
12d ago
AMGN Earnings: Amgen Surges After Raised Forecast, Weight Loss Drug Update
PremiumMarket NewsAMGN Earnings: Amgen Surges After Raised Forecast, Weight Loss Drug Update
12d ago
Amgen price target raised to $307 from $284 at UBS
PremiumThe Fly
Amgen price target raised to $307 from $284 at UBS
12d ago
William Blair upgrades Amgen on confidence in upcoming obesity data
PremiumThe Fly
William Blair upgrades Amgen on confidence in upcoming obesity data
12d ago
Amgen narrows FY24 adjusted EPS view to $19.00-$20.20 from $18.90-$20.30
PremiumThe FlyAmgen narrows FY24 adjusted EPS view to $19.00-$20.20 from $18.90-$20.30
12d ago
Amgen reports Q1 adjusted EPS $3.96, consensus $3.87
PremiumThe Fly
Amgen reports Q1 adjusted EPS $3.96, consensus $3.87
12d ago
Notable companies reporting after market close
PremiumThe Fly
Notable companies reporting after market close
12d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100